Compare Novavax Inc (NVAX) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Zillow Group Inc Class C — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Zillow Group Inc Class C trades at $31.8 (market cap $7.54B). The key difference: Zillow Group Inc Class C is far larger — about 5.8× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| NVAX | Z | |
|---|---|---|
Market Cap | $1.30B | $7.54B |
Sector | Health | Media |
52-Week High | $11.19 | $90.35 |
52-Week Low | $6.22 | $29.41 |
Enterprise Value | $800.50M | $7.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
